Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling.

by Ikuo Nakamura, Kais Zakharia, Bubu A Banini, Dalia S Mikhail, Tae Hyo Kim, Ju Dong Yang, Catherine D Moser, Hassan M Shaleh, Sarah R Thornburgh, Ian Walters, Lewis R Roberts
Published 2014-01-01

Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling.

by Ikuo Nakamura, Kais Zakharia, Bubu A Banini, Dalia S Mikhail, Tae Hyo Kim, Ju Dong Yang, Catherine D Moser, Hassan M Shaleh, Sarah R Thornburgh, Ian Walters, Lewis R Roberts
Published 2015-01-01

Methodology of a multispecialty outpatient Obesity Treatment Research Program

by Dalia S. Mikhail, Teresa B. Jensen, Todd W. Wade, Jane F. Myers, Jennifer M. Frank, Mark Wieland, Don Hensrud, M. Molly McMahon, Maria L. Collazo-Clavell, Haitham Abu-Lebdeh, Kurt A. Kennel, Daniel L. Hurley, Karen Grothe, Michael D. Jensen
Published 2018-06-01